Entwicklungsansätze für Impfstoffe gegen Hepatitis-C-Virus-Infektionen

Pharmacology, Toxicology and Pharmaceutical Science

• Virus Vaccine 100%
• Epitope 50%
• Antiviral Therapy 50%
• Vaccine Development 50%
• Virus Envelope Protein 50%
• mRNA Vaccine 50%
• Neutralizing Antibody 50%
• Virus Transmission 50%

Immunology and Microbiology

• Virus Vaccine 100%
• Virus Transmission 50%
• Cytotoxic T Cell 50%
• Viral Envelope Protein 50%
• Maturation 50%
• Epitope 50%
• Neutralizing Antibody 50%